ALPHATEC HOLDNGS INC (ATEC)
Sector: Health Care
Sector: Health Care
ALPHATEC HOLDNGS INC - Executive Compensation
Executive Vice President and Chief Financial Officer
Executive Compensation
J. Todd Koning serves as the Executive Vice President and Chief Financial Officer at ALPHATEC HOLDINGS INC, a prominent medical technology company focused on the design, development, and advancement of products for the surgical treatment of spinal disorders. Koning joined ALPHATEC HOLDINGS INC in 2017, bringing with him a wealth of experience in financial leadership and strategic planning. His role at the company involves overseeing the financial operations, ensuring fiscal responsibility, and driving growth initiatives that align with the company's mission to improve patient outcomes through innovative spinal solutions. Prior to his tenure at ALPHATEC HOLDINGS INC, Koning held significant positions in the financial sector, including serving as the Chief Financial Officer at ZELTIQ Aesthetics, Inc., where he played a pivotal role in the company's successful initial public offering (IPO) and subsequent acquisition by Allergan. His strategic financial management and deep understanding of the healthcare industry have been instrumental in guiding ALPHATEC HOLDINGS INC through periods of growth and transformation. Koning's leadership has been crucial in enhancing the company's financial stability and supporting its expansion efforts, particularly in the development and commercialization of new spinal technologies. Koning's achievements extend beyond his corporate roles, as he is also recognized for his contributions to the broader financial and healthcare communities. He holds a Bachelor of Science degree in Accounting from the University of Utah and is a Certified Public Accountant (CPA). His expertise in financial strategy and corporate governance has earned him respect among peers and stakeholders alike. At ALPHATEC HOLDINGS INC, Koning continues to lead with a focus on sustainable growth and innovation, ensuring that the company remains at the forefront of the spinal surgery industry.